Mayo Clinic researchers identify new targeted immunotherapy for ovarian cancer

Overweight-to-Obese Trajectory in Adulthood May Raise Ovarian Cancer Risk

Individuals who transition from overweight to obese during adulthood may face a higher ovarian cancer risk, highlighting the importance of tracking body fat changes.

A 32-year-old woman gave birth to her baby twice for an ovarian cancer diagnosis, and the uterus had to be removed for two hours.

Newswise — ROCHESTER, Minn. — Mayo Clinic researchers have discovered that a novel immunotherapy target, a cryptic antigen, may be key to helping the immune system fight ovarian cancer. The study, published in Sciences Advances, may refine treatment approaches for this type of cancer. Ovarian cancer, with its subtle symptoms, can go undetected until it spreads. In later stages of the disease, treatment becomes more complicated, with immunotherap…

Mayo Clinic researchers have discovered that a new immunotherapy target, a cryptic antigen, may hold the key to helping the immune system fight ovarian cancer. The study, published in Sciences Advances, could improve treatment approaches for this type of cancer.